Healios (Ophthalmic Surgical Adjuvant Business) is Drug Discovery in Japan that focus on surgery adjuvants business. They cover business area such as developer, ophthalmological surgery adjuvant, stain propriety, ophthalmic surgery, patient, ophthalmic disease.
-
Surgery Adjuvants
-
2-4-1 Hamamatsucho, Minato-ku
World Trade Center Building 15F
Tokyo, 105-6115
Japan
Private
developerophthalmological surgery adjuvantstain proprietyophthalmic surgerypatientophthalmic disease
* We use standard office opening hours in near Healios (Ophthalmic Surgical Adjuvant Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Healios (Ophthalmic Surgical Adjuvant Business) is Drug Discovery business from Japan that founded in - ( years old in ), Healios (Ophthalmic Surgical Adjuvant Business) business is focusing on Surgery Adjuvants.
Healios (Ophthalmic Surgical Adjuvant Business) headquarter office and corporate office address is located in 2-4-1 Hamamatsucho, Minato-ku World Trade Center Building 15F Tokyo, 105-6115 Japan.
Healios (Ophthalmic Surgical Adjuvant Business) was founded in Japan.
In , Healios (Ophthalmic Surgical Adjuvant Business) is currently focus on surgery adjuvants sector.
Above is snippet of Google Trends for "surgery adjuvants" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Healios (Ophthalmic Surgical Adjuvant Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
